Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema
Ravdeep Kaur, Aerik Anthony Williams, Catherine Baker Swift, Jason W Caldwell
Wake Forest University School of Medicine, Wake Forest University, Winston-Salem, NC, USA
Abstract: Acquired angioedema is often associated with significant morbidity. An underlying lymphatic malignancy, autoimmune disorder, adenocarcinoma, or other malignancy may be present. Screening for these disorders should occur in all patients with acquired angioedema as treatment may result in resolution of angioedema.
Keywords: complement, C1-INH deficiency, ecallantide, hemopathy
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]